USPTO serial 76378354
TIPOROS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- LEIPZIG, MARC J
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with TIPOROS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
3723 MB Bilthoven, NL
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Michael B. Lasky
MICHAEL B LASKY ALTERAL LAW GROUP.6500 CITY W PKWY #100MINNEAPOLIS, MN 55344UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals used in industry or science, namely ceramic materials for use in the manufacture of matrixes for controlled release of medicines, bone fillers, artificial bone, joints and implants; polymer beads or pallets for use in manufacturing; carrier material for the cultivation of cells, for use in vitro, scientific or research use | ACTIVE | — |
| 005 | Pharmaceutical preparations, excluding hypolipidemic and cardiovascular preparations, in the nature of medicinal ceramic preparations for use in the controlled release of medicines for the treatment of bone and cardiovascular diseases; polymers to be used as bone fillers for medical purposes; bone fillers for medical purposes; polymers to be used as a matrix for controlled release of pharmaceutical preparations; pharmaceutical preparations for controlled release for the treatment of damaged tissue, cardiovascular diseases, Central Nerves System (CNS), gastrointestinal, oncology, infections, pulmonary, endocrinology, genito-urinary tract, ocular; medical diagnostic reagents for the cultivation of cells; food for medically restricted diets; food for babies; medical plasters, wound, burn and surgical dressings; material for stopping teeth, dental wax; all purpose disinfectants | ACTIVE | — |
| 010 | Surgical, medical, dental and veterinary apparatus and instruments, excluding insulation-control equipment for rooms for medical use, namely cement restrictors and hand-held bone filling equipment for bone repair; artificial limbs, eyes and teeth; artificial cartilage, bone and skin; orthopaedic joint implants; orthopaedic articles, namely ceramic materials as implants or as coatings on implants, ceramic cement compositions, spacers, cartilage, muscles, suture anchors, tendons and ligaments; bone implants composed of artificial materials in the nature of cement; bone implants composed of artificial ceramic materials; sutures | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 14, 2004 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Feb 20, 2004 | CFIT | CASE FILE IN TICRS | — |
| Oct 2, 2003 | CNSI | INQUIRY AS TO SUSPENSION MAILED | — |
| Feb 11, 2003 | CNSL | LETTER OF SUSPENSION MAILED | — |
| Dec 26, 2002 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 26, 2002 | PAPER RECEIVED | — | |
| Jun 27, 2002 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 21, 2002 | DOCK | ASSIGNED TO EXAMINER | — |